Blenrep

==2020–2022==
Blenrep was approved under the United States Food and Drug Administration's accelerated approval program in 2020. In November 2022, the drug was withdrawn from markets after the DREAMM-3 phase III confirmatory trial, as it had failed to meet the requirements of the FDA's accelerated approval regulations.
Category:GSK
Category:Drugs
Category:Pharmaceutical
Category:Prescription medicines
Category:Defunct
Category:Discontinued
Category:Defunct brands
Category:Discontinued drug brands
Category:Medicines in the United States
Category:United States
Category:2020s
Category:2020